Risk of confusion in dosing Tamiflu oral suspension in children

New England Journal of Medicine

Volumn 361, Issue 19, 2009, Pages 1912-1913

  Parker, Ruth M ^a   Wolf, Michael S ^b   Jacobson, Kara L ^a   Wood, Alastair J J ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Symphony Capital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

CALIBRATION; CHILD; DRUG DOSE REGIMEN; DRUG LABELING; DRUG PACKAGING; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; LETTER; MEDICATION ERROR; PRESCHOOL CHILD; PRIORITY JOURNAL; SUSPENSION; SYRINGE;

EID: 70350784091     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0908840     Document Type: Letter

References (2)

1. Centers for Disease Control and Prevention. Emergency use authorization of Tamiflu: fact sheet for patients and parents. July 14, 2009. (Accessed September 22, 2009, at http://www.cdc.gov/h1n1flu/eua/pdf/tamiflu-patients.pdf.)
2. Idem. Emergency use authorization (EUA) of medical products and devices: Tamiflu (oseltamivir). (Accessed September 22, 2009, at http://www.cdc.gov/ h1n1flu/eua/pdf/fda-letter-tamiflu.pdf.)